GANX Gain Therapeutics
- 1.480
- -0.015-1.00%
- 1.500
- +0.020+1.35%
Gain Therapeutics News
Gain Therapeutics | 424B5: Prospectus
Gain Therapeutics | 8-K: Current report
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Islam Khalid
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mack Gene
Gain Therapeutics | 10-Q: Q2 2024 Earnings Report
Gain Therapeutics | 8-K: Gain Therapeutics Reports Financial Results for Second Quarter 2024 and Provides Corporate Update
Gain Therapeutics | 8-K: Current report
Gain Therapeutics | 8-K: Current report
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RICHMAN ERIC I
Gain Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Gain Therapeutics | 8-K: Current report
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Islam Khalid
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Melincoff Gwen A
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HASLER HANS PETER
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nicaise Claude
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RICHMAN ERIC I
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Riley Jeffrey Scott
Gain Therapeutics | 8-K: Current report
Gain Therapeutics | 424B5: Prospectus
Gain Therapeutics | 8-K: Current report
Analysis
Price Target
No Data
No Data